Meta-Analysis of the Relationship between TNF-α (−308G/A) and IL-10 (−819C/T) Gene Polymorphisms and Susceptibility to Dengue

References

• Acioli-Santos B, Segat L, Dhalia R, et al. 2008. MBL2 gene polymorphisms protect against development of thrombocytopenia associated with severe dengue phenotype. Hum immunrol 69:122–128.
   PubMed Web of Science ®Google Scholar
• Ahmadi A, Hajilooi M, Solgi G, et al. 2015. Interleukin-4 receptor alpha T1432C and A1652G polymorphisms are associated with risk of visceral leishmaniasis. Adv Biomed Res 4:195.
   Google Scholar
• Alagarasu K, Bachal RV, Tillu H, et al. 2015. Association of combinations of interleukin-10 and pro-inflammatory cytokine gene polymorphisms with dengue hemorrhagic fever. Cytokine 74:130–136.
   PubMed Web of Science ®Google Scholar
• Alagarasu K, Mulay AP, Singh R, et al. 2013. Association of HLA-DRB1 and TNF genotypes with dengue hemorrhagic fever. Hum immunol, 74, 610–617.
   PubMed Web of Science ®Google Scholar
• Bhatt S, Gething PW, Brady OJ, et al. 2013. The global distribution and burden of dengue. Nature 496:504–507.
   PubMed Web of Science ®Google Scholar
• Boonnak K, Dambach KM, Donofrio GC, et al. 2011. Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection. J Virol 85:1671–1683.
   PubMed Web of Science ®Google Scholar
• Chareonsirisuthigul T, Kalayanarooj S, Ubol S. 2007. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. J Gen Virol 88:365–375.
   PubMed Web of Science ®Google Scholar
• Chaturvedi UC, Nagar R, Shrivastava R. 2006. Dengue and dengue haemorrhagic fever: implications of host genetics. FEMS Immunol Medical Microbiol 47:155–166.
   PubMedGoogle Scholar
• Chuansumrit A, Anantasit N, Sasanakul W, et al. 2013. Tumour necrosis factor gene polymorphism in dengue infection: association with risk of bleeding. Paediatr Int Child Health 33:97–101.
   PubMed Web of Science ®Google Scholar
• Costa VV, Fagundes CT, Souza DG, et al. 2013. Inflammatory and innate immune responses in dengue infection: protection versus disease induction. Am J Pathol 182:1950–1961.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. 1986. Meta-analysis in clinical trials. Control Clin Trials 7:177–188.
   PubMed Web of Science ®Google Scholar
• Dettogni RS, Tristão-Sá R, dos Santos M, et al. 2015. Single nucleotide polymorphisms in immune system genes and their association with clinical symptoms persistence in dengue-infected persons. Hum immunol 76:717–723.
   PubMed Web of Science ®Google Scholar
• Doeschl-Wilson AB, Davidson R, Conington J, et al. 2011. Implications of host genetic variation on the risk and prevalence of infectious diseases transmitted through the environment. Genetics 188:683–693.
   PubMed Web of Science ®Google Scholar
• Egger M, Smith GD, Phillips AN. 1997. Meta-analysis: principles and procedures. BMJ 315:1533.
   Google Scholar
• El Ghannam D, Fawzy IM, Azmy E, et al. 2015. Relation of interleukin-10 Promoter Polymorphisms to Adult Chronic Immune Thrombocytopenic Purpura in a Cohort of Egyptian Population. Immunol Invest 44:616–626.
   PubMed Web of Science ®Google Scholar
• Elahi MM, Asotra K, Matata B, et al. 2009. Tumor necrosis factor alpha− 308 gene locus promoter polymorphism: an analysis of association with health and disease. BBA-Mol Basis Dis 1792:163–172.
   PubMed Web of Science ®Google Scholar
• Fang X, Hu Z, Shang W, et al. (2012). Genetic polymorphisms of molecules involved in host immune response to dengue virus infection. FEMS Immunol Med Microbiol 66:134–146.
   PubMedGoogle Scholar
• Fernandez‐Mestre MT, Gendzekhadze K, Rivas‐Vetencourt P, et al. 2004. TNF‐α‐308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients. Tissue Antigens 64:469–472.
   PubMed Web of Science ®Google Scholar
• Fernando AN, Malavige GN, Perera KLN, et al. 2015. Polymorphisms of transporter associated with antigen presentation, tumor necrosis factor-α and interleukin-10 and their implications for protection and susceptibility to severe forms of dengue fever in patients in Sri Lanka. J Global Infectious Dis 7:157.
   Web of Science ®Google Scholar
• Ferreira RAX, de Oliveira SA, Gandini M, et al. 2015. Circulating cytokines and chemokines associated with plasma leakage and hepatic dysfunction in Brazilian children with dengue fever. Acta Trop 149:138–147.
   PubMed Web of Science ®Google Scholar
• Gane JM, Stockley RA, Sapey E. 2015. The rs361525 polymorphism does not increase production of tumor necrosis factor alpha by monocytes from alpha-1 antitrypsin deficient subjects with chronic obstructive pulmonary disease-a pilot study. J Negat Results BioMed 14:1.
   Google Scholar
• García-Trejo AR, Falcón-Lezama JA, Juárez-Palma L, et al. 2011. Tumor necrosis factor alpha promoter polymorphisms in Mexican patients with dengue fever. Acta Trop 120:67–71.
   PubMed Web of Science ®Google Scholar
• Grange L, Simon-Loriere E, Sakuntabhai A, et al. 2015. Epidemiological risk factors associated with high global frequency of inapparent dengue virus infections. Protective Immune Response to Dengue Virus Infection and Vaccines. Front Immunol 14:1–4.
   Google Scholar
• Guabiraba R, Ryffel B. 2014. Dengue virus infection: Current concepts in immune mechanisms and lessons from murine models. Immunology 141:143–156.
   PubMed Web of Science ®Google Scholar
• Gurugama P, Garg P, Perera J, et al. 2010. Dengue viral infections. Indian J Dermatol 55:68.
   Google Scholar
• Herrero LJ, Zakhary A, Gahan ME, et al. 2013. Dengue virus therapeutic intervention strategies based on viral, vector and host factors involved in disease pathogenesis. Pharmacol Ther 137:266–282.
   PubMed Web of Science ®Google Scholar
• Higgins J, Thompson SG. 2002. Quantifying heterogeneity in a meta‐analysis. Stat Med 21:1539–1558.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. 2003. Measuring inconsistency in meta-analyses. BMJ 327:557–560.
   PubMed Web of Science ®Google Scholar
• Kazemi S, Saidijam M, Hashemi SH, et al. 2016. Analysis of IL-10 and IL-6 Gene Polymorphisms and Their Serum Levels in Patients with Brucellosis: A Case Control Study. Immunol Invest 45:107–115.
   PubMed Web of Science ®Google Scholar
• Ke Z, Yuan L, Ma J, et al. 2015. IL-10 Polymorphisms and Tuberculosis Susceptibility: An Updated Meta-Analysis. Yonsei Med J 56:1274–1287.
   PubMed Web of Science ®Google Scholar
• Lan, NTP, Hirayama K. 2011. Host genetic susceptibility to severe dengue infection. Trop Med Health 39:73–81.
   PubMedGoogle Scholar
• Malavige GN, Gomes L, Alles L, et al. 2013. Serum IL-10 as a marker of severe dengue infection. BMC Infect Dis 13:341.
   Web of Science ®Google Scholar
• Maranhão RMA, Esteves FAM, Crovella S, Segat L, Souza PRE. 2015. Tumor Necrosis Factor-α and Interleukin-6 gene polymorphism association with susceptibility to celiac disease in italian patients. Genet Mol Res 14:16343–16352.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. 2009. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement 151:264–269.
   Google Scholar
• Mustafa MS, Rasotgi V, Jain S, et al. 2015. Discovery of fifth serotype of dengue virus (DENV-5): A new public health dilemma in dengue control. Med J Armed Forces India 71:67–70.
   PubMedGoogle Scholar
• Nardin, E. 2009. Genetic Polymorphisms and Immune Responses. Immunol Invest 38:198–202.
   PubMed Web of Science ®Google Scholar
• Nicodemus KK. 2008. Catmap: Case-control and TDT meta-analysis package. BMC Bioinf 9:1.
   Web of Science ®Google Scholar
• Perez AB, Sierra B, Garcia G, et al. 2010. Tumor necrosis factor–alpha, transforming growth factor–β1, and interleukin-10 gene polymorphisms: implication in protection or susceptibility to dengue hemorrhagic fever. Hum Immunol 71:1135–1140.
   PubMed Web of Science ®Google Scholar
• Pozzetto B, Memmi M, Garraud O. 2015. Is transfusion-transmitted dengue fever a potential public health threat? World J Virol 4:113.
   Google Scholar
• Pregunta, L. 2007. A estratégia PICO para a construção da pergunta de pesquisa e busca de evidências. Rev Latino-am Enfermagem 15(3).
   Google Scholar
• Qidwai T, Khan F. 2011. Tumour necrosis factor gene polymorphism and disease prevalence. Scand J Immunol 74:522–547.
   PubMed Web of Science ®Google Scholar
• Rathakrishnan A, Wang SM, Hu Y, et al. 2012. Cytokine expression profile of dengue patients at different phases of illness. PloS One 7:e52215.
   PubMed Web of Science ®Google Scholar
• Rothman AL. 2011. Immunity to dengue virus: A tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol 11:532–543.
   PubMed Web of Science ®Google Scholar
• Sam SS, Teoh BT, Chinna K, et al. 2015. High producing tumor necrosis factor alpha gene alleles in protection against severe manifestations of dengue. Int J Med Sci 12:177.
   Web of Science ®Google Scholar
• Shi YJ, Jiang ZY, Zeng K. 2006. Effect of IL-6 and TNF-α on dengue virus infection of human dendritic cells. Chinese J Cell Molec Immunol 22:469–471.
   Google Scholar
• Simmons CP, McPherson K, Chau NVV, et al. 2015. Recent advances in dengue pathogenesis and clinical management. Vaccine 33:7061–7068.
   PubMed Web of Science ®Google Scholar
• Srikiatkhachorn A, Green S. 2010. Markers of dengue disease severity. Curr Top Microbiol Immunol 338:67–82.
   PubMed Web of Science ®Google Scholar
• Tsai TT, Chuang Y J, Lin YS, et al. 2013. An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection. J Biomed Sci 20:1.
   Web of Science ®Google Scholar
• Vejbaesya S, Luangtrakool P, Luangtrakool K, et al. 2009. TNF and LTA gene, allele, and extended HLA haplotype associations with severe dengue virus infection in ethnic Thais. J Infect Dis 199:1442–1448.
   PubMed Web of Science ®Google Scholar
• Wilson AG, Symons JA, McDowell TL, et al. 1997. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA 94:3195–3199.
   PubMed Web of Science ®Google Scholar
• World Health Organization. 1997. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. 2nd edition. Geneva: World Health Organization. Accessed 27 February 2016. Available in: http://www.who.int/csr/resources/publications/dengue/Denguepublication/en/.
   Google Scholar
• World Health Organization. 2009. Dengue: Guidelines for Diagnosis, Treatment, Prevention, and Control. Special Programme for Research and Training in Tropical Diseases. Accessed 25 February 2016. Available: http://www.who.int/tdr/publications/documents/denguediagnosis.pdf.
   Google Scholar
• World Health Organization. 2013. “WHO|Dengue and Severe Dengue.” Accessed 14 May 2016. http://www.who.int/mediacentre/factsheets/fs117/en/.
   Google Scholar
• Xavier-Carvalho C, Gibson G, Brasil P, et al. 2013. Single nucleotide polymorphisms in candidate genes and dengue severity in children: A case–control, functional and meta-analysis study. Infect, Genet Evol 20:197–205.
   PubMed Web of Science ®Google Scholar
• Yang YH, Liu YQ, Zhang L, et al. 2015. Genetic polymorphisms of the TNF-α-308G/A are associated with metabolic syndrome in asthmatic patients from Hebei province, China. Int J Clin Exp Pathol 8:13739.
   Web of Science ®Google Scholar